![Frederic Godderis](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Frederic Godderis
Geschäftsführer bei Tranquis Therapeutics, Inc.
Profil
Frederic Godderis currently works at Tranquis Therapeutics, Inc., as Chief Operating Officer from 2021.
Mr. Godderis received his graduate degree from Katholieke Universiteit Leuven.
Aktive Positionen von Frederic Godderis
Unternehmen | Position | Beginn |
---|---|---|
Tranquis Therapeutics, Inc.
![]() Tranquis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tranquis Therapeutics, Inc. discovers and develops novel immuno-therapeutics for neurological diseases. It offers treatment for central nervous system (CNS) disorders, including Amyotrophic Lateral Sclerosis, Parkinson 's disease, Alzheimer?s Disease, and age-related neuropathology. The company was founded by Chih-Ping Liu and Khoa D. Nguyen in June 2016 and is headquartered in Menlo Park, CA. | Geschäftsführer | 26.05.2021 |
Ausbildung von Frederic Godderis
Katholieke Universiteit Leuven | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Tranquis Therapeutics, Inc.
![]() Tranquis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tranquis Therapeutics, Inc. discovers and develops novel immuno-therapeutics for neurological diseases. It offers treatment for central nervous system (CNS) disorders, including Amyotrophic Lateral Sclerosis, Parkinson 's disease, Alzheimer?s Disease, and age-related neuropathology. The company was founded by Chih-Ping Liu and Khoa D. Nguyen in June 2016 and is headquartered in Menlo Park, CA. | Health Technology |